NorthWest Biotherapeutics Inc (NWBO)

[attilathehunt]

So why launch a consultation now?
Because this is not a scientific need. It’s regulatory cover. The MHRA is likely preparing to approve a treatment without a traditional randomized control arm — and wants procedural insulation from criticism. They’re building a paper trail that says: “We asked the scientific community first.”

And most likely, in the future, they will be many other submissions with RWE and thus want to establish a CYA process.

I wonder where the clock stands on this? Is it on? Or is it off?

If what you state is true, then August 30% / September 70% is the likely decision period. Good thing I am patient...I hope my patience outlast my aging mind and body!

The Happenings....See you in September!!!

Have a good time....But remember. There is danger (fudsters) in the summer moon above...